
Arcutis Biotherapeutics Investor Relations Material
Latest events

Q4 2024
Arcutis Biotherapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Arcutis Biotherapeutics Inc
Access all reports
Arcutis Biotherapeutics Inc. is a biopharmaceutical company focused on developing treatments for immune-mediated dermatological conditions. The company aims to address unmet needs in the dermatology field by creating therapies that offer improved safety and efficacy profiles for patients. Arcutis Biotherapeutics develops topical treatments for a range of skin conditions, leveraging its expertise in immunology and drug delivery to target diseases affecting the skin, hair, and nails. Its pipeline includes therapies designed to manage chronic inflammatory skin diseases. The company is headquartered in Westlake Village, California, and its shares are listed on the NASDAQ.
Key slides for Arcutis Biotherapeutics Inc


Q1 2024
Arcutis Biotherapeutics Inc


Q2 2024
Arcutis Biotherapeutics Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ARQT
Country
🇺🇸 United States